Using the MOLM-14/Luc/GFP xenograft model, mice were administered daily treatment with FLT3 and CXCR4 inhibitors after achieving high levels of leukemia chimerism in the blood (Figure S4A). This evidence concerns the gene CXCR4 and leukemia.